Europe Percutaneous Mechanical Circulatory Support Devices Market Analysis by 2027

The Europe percutaneous mechanical circulatory support devicesmarketis expected to reach US$ 1,199.73 million by 2027 from US$ 456.23 million in 2019;it is estimated to grow at a CAGR of 13.1% from 2020 to 2027.

Percutaneous mechanical circulatory support devices market offers an effective and rapid approach to slow the downward spiral of hemodynamic instability among patients suffering with decompensated heart failures and cardiogenic shocks till a more definitive strategy is perceived among patients to recover from these cardiac ailments. The major roles of the percutaneous mechanical circulatory support devices include improving the native cardiac output, reducing ventricular volume and filling pressures, augmenting coronary perfusion, and maintaining vital organ perfusion.

Heart disease is the leading cause of death for people in Europe. According to the Centers for Disease Control and Prevention (CDC), in 2016 Cardiovascular disease (CVD) causes more than half of all deaths across the European Union Region. CVD causes 46 times the number of deaths and 11 times the disease burden caused by AIDS, malaria and tuberculosis combined in Europe. 80% of premature heart disease and stroke is preventable in natrure. The Centers for Disease Control and Prevention (CDC) reports that about half of people who develop heart failure die within five years of diagnosis.

Various research studies show that improvements and experience with percutaneous mechanical circulatory support may offer the prospect of better outcomes. Thus, the high prevalence of cardiovascular diseases that majorly includes heart failure conditions rising across European region to which mechanical circulatory devices have emerged as potential solutions for patients’ treatment is likely to boost the growth of the percutaneous mechanical circulatory support devices market.

The chronic shortage of heart donors has also led to extend the age limits of donors in certain areas. Thus, the solution to this shortage of heart donors served by the temporarily used percutaneous mechanical circulatory support devices that are also helpful in long-term support for patients suffering from heart failures is likely to be adopted at higher rates in the coming years.

Among all European countries, Spain, Italy, Germany, France, and the UK are most affected due to the increasing number of COVID-19 cases and deaths associated with it. For instance, the outbreak of the COVID-19 pandemic across the in Germany and Spain has resulted in the frozen production of various medical devices. As various hospitals and healthcare organizations are struggling with the spread of disease, various medical device companies have diverted their focus in producing personal protection equipment. Therefore, it expected that the market for the percutaneous mechanical circulatory support devices would witness slow growth in the coming one or two years.

Rest of Europe Percutaneous Mechanical Circulatory Support DevicesMarket,Revenue and Forecast to 2027 (US$ Mn)

EUROPEPERCUTANEOUS MECHANICAL CIRCULATORY SUPPORT DEVICES MARKET SEGMENTATION

By Product

• Intra-Aortic Balloon Pumps
• VA-Extracorporeal Membrane Oxygenation (ECMO)
• Short-Term Ventricular Assist Devices (VADs)
  • Impella
  • Tandem Heart

By End User

• Hospitals
• Ambulatory Surgical Centers
• Others

By Country

• Germany
• UK
• France
• Italy
• Spain

Company Profiles

• Getinge AB
• Livanova Plc (Cardiacassist, Inc)
• Eurosets
• Berlin Heart
• CardiobridgeGmbh
• Medtronic

Europe Percutaneous Mechanical Circulatory Support Devices Report Scope